Katie Brockman
- Indexed articles, last 90 days
- 46
- Latest publication
- Sep 22, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Vanguard S&P 500 Growth ETF (VOOG) vs. iShares Russell 2000 Growth ETF (IWO): Which ETF Is the Better Buy for Investors? (opens the original)
Read excerpt
Choosing between the Vanguard S&P 500 Growth ETF (NYSEMKT:VOOG) and the iShares Russell 2000 Growth ETF (NYSEMKT:IWO) involves weighing the stability and momentum of established industry leaders against the potential of small-cap innovators. While both focus on growth-oriented companies, their portfolio concentrations and market-cap focuses result in distinct risk and reward profiles. Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the availab
Warren Buffett Says Bear Markets Are an "Investor's Best Friend." Decades of History Prove He's 100% Right. (opens the original)
Read excerpt
The September effect appears to be in full swing, as major market indexes have struggled during this historically slow month. The S&P 500 (SNPINDEX: ^GSPC), Dow Jones Industrial Average (DJINDICES: ^DJI), and Nasdaq Composite (NASDAQINDEX: ^IXIC) have fallen by 1%, 3%, and 0.3%, respectively, over the last two weeks, as of this writing. A rate hike from the Federal Reserve, stubbornly high oil prices, and AI concerns have put pressure on stocks, and a rattled bond market has renewed recession fe
The Stock Market Is Sending a Rare Historical Warning. Warren Buffett Says Investors Should Make This 1 Move. (opens the original)
Read excerpt
After years of seemingly unstoppable growth, major market indexes have faltered. The S&P 500 (SNPINDEX: ^GSPC), Dow Jones Industrial Average (DJINDICES: ^DJI), and Nasdaq Composite (NASDAQINDEX: ^IXIC) all slipped into the red over the last month, each down between 1% and 2%, as of this writing. There's no shortage of reasons why the market is struggling. New fears around AI are rattling tech stocks, oil prices are reaching new highs, uncertainty in the bond market is pushing yields to dangerous
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? (opens the original)
Read excerpt
Healthcare investors often choose between targeting high-growth sub-sectors or capturing the broader market. The Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) provides a concentrated approach to the biotech industry, while the Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) offers broader exposure with lower volatility. Here's how the two compare on the most important factors for investors. Beta measures price volatility relative to the S&P 500; beta is calculated from monthly ret
IEMG vs SCHE: Which Emerging Markets ETF Is the Smarter Choice Right Now? (opens the original)
Read excerpt
Both the iShares Core MSCI Emerging Markets ETF (NYSEMKT:IEMG) and the Schwab Emerging Markets Equity ETF (NYSEMKT:SCHE)serve as core building blocks for international diversification, targeting stocks across developing nations. While they share similar goals, differences in their underlying indexes lead to varying sector exposures, which can impact long-term risk and return profiles. Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the availab
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.